Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia

NCT02151253 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Nocturia
Daytime Sleepiness

Interventions

DRUG: Armodafinil
DRUG: Placebo

Sponsor

Duke University